XML 35 R22.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Note P - Stock Options | 12 Months Ended
--- | ---
Dec. 31, 2015
Notes to Financial Statements |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | NOTE P—STOCK OPTIONS 1999 Stock Option Plan During 1999, the Board of Directors of the Company adopted the 1999 Stock Option Plan (the 1999 Plan). The 1999 Plan was not presented to stockholders for approval and thus incentive stock options are not available under the plan. Under the 1999 Plan, 1,000,000 shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which may not be below 85% of fair market value. The term of nonstatutory stock options granted may not exceed ten years. Options issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, as defined, all options outstanding vest immediately. The 1999 Plan expired in August 2009. 2004 Stock Option Plan On October 12, 2004, the Board of Directors of the Company approved the 2004 Stock Option Plan (the 2004 Plan). The 2004 Plan has not yet been presented to stockholders for approval and thus incentive stock options are not available under this plan. Under the terms of this plan, 2,000,000 post-split shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which may not be below 85% of fair market value. The term of stock options granted may not exceed ten years. Options issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, as defined, all options outstanding vest immediately. The Plan expired in October 2014. 2015 Stock Option Plan On January 27, 2016, the shareholders approved the 2015 Equity Incentive Plan (the 2015 Plan). Under the terms of this plan, 8,000,000 post-split shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which may not be below 100-110% of fair market value. The term of stock options granted may not exceed ten years. Options issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, certain stock awards issued under this plan may be subject to additional acceleration of vesting as may be provided in the participants’ written agreement. The Plan expires in December 2025. Non-Plan Stock Options Periodically, the Company has granted options outside of the 1999 and 2004 Plans to various employees and consultants. In the event of change in control, as defined, certain of the non-plan options outstanding vest immediately. Stock Option Activity Information summarizing option activity is as follows:
|  | Number of Options |  |  | Weighted average exercise |  |  | Weighted average remaining life |  |  | Aggregate intrinsic |
|  | 1999 Plan |  |  | 2004 Plan |  |  | Non Plan |  |  | Total |  |  | price |  |  | (in years) |  |  | value |
Outstanding, as of December 31, 2013 |  |  | 250,000 |  |  |  | 1,845,304 |  |  |  | 600,000 |  |  |  | 2,695,304 |  |  | $ | 0.33 |  |  |  |  |  |  |  |  |
Granted |  |  | — |  |  |  | — |  |  |  | 1,835,000 |  |  |  | 1,835,000 |  |  |  | 0.39 |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | (54,166 | ) |  |  | — |  |  |  | (54,166 | ) |  |  | 0.25 |  |  |  |  |  |  |  |  |
Forfeited |  |  | — |  |  |  | (129,168 | ) |  |  | (225,000 | ) |  |  | (354,168 | ) |  |  | 0.34 |  |  |  |  |  |  |  |  |
Expired |  |  | — |  |  |  | (26,665 | ) |  |  | — |  |  |  | (26,665 | ) |  |  | 0.29 |  |  |  |  |  |  |  |  |
Outstanding, as of December 31, 2014 |  |  | 250,000 |  |  |  | 1,635,305 |  |  |  | 2,210,000 |  |  |  | 4,095,305 |  |  | $ | 0.36 |  |  |  | 4.45 |  |  | $ | 24,325 |
Granted |  |  | — |  |  |  | — |  |  |  | 1,428,000 |  |  |  | 1,428,000 |  |  |  | 0.18 |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  |  | — |  |  |  | (41,667 | ) |  |  | (462,585 | ) |  |  | (504,252 | ) |  |  | 0.31 |  |  |  |  |  |  |  |  |
Expired |  |  | — |  |  |  | (573,638 | ) |  |  | (66,582 | ) |  |  | (640,220 | ) |  |  | 0.25 |  |  |  |  |  |  |  |  |
Outstanding, as of December 31, 2015 |  |  | 250,000 |  |  |  | 1,020,000 |  |  |  | 3,108,833 |  |  |  | 4,378,833 |  |  | $ | 0.32 |  |  |  | 4.57 |  |  | $ | 240 |
Subject to vesting at December 31, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,628,853 |  |  | $ | 0.34 |  |  |  | 4.22 |  |  | $ | 129 |
Exercisable at December 31, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,931,653 |  |  | $ | 0.38 |  |  |  | 2.94 |  |  | $ | 0 |
The options outstanding and exercisable at December 31, 2015 were in the following exercise price ranges:
|  |  |  |  |  | Options Outstanding |  |  | Options Exercisable |
Range of exercise prices |  |  | Number of shares |  |  | Weighted average exercise price |  |  | Weighted average remaining life (in years) |  |  | Number exercisable |  |  | Weighted average exercise price |
$ | 0.15 | - | 0.40 |  |  |  | 2,893,000 |  |  | $ | 0.24 |  |  |  | 4.68 |  |  |  | 1,244,167 |  |  | $ | 0.28 |
| 0.41 | - | 0.79 |  |  |  | 1,280,833 |  |  |  | 0.41 |  |  |  | 5.18 |  |  |  | 482,486 |  |  |  | 0.41 |
| 0.80 | - | 0.92 |  |  |  | 205,000 |  |  |  | 0.90 |  |  |  | 1.02 |  |  |  | 205,000 |  |  |  | 0.90 |
$ | 0.15 | - | 0.92 |  |  |  | 4,378,833 |  |  |  |  |  |  |  |  |  |  |  | 1,931,653 |  |  |  |  |
The aggregate intrinsic value in the table above represents the total intrinsic value, based on the Company’s closing stock price of $0.16 as of December 31, 2015, which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options exercisable as of December 31, 2015 was 0. The weighted average fair value of options granted during the years ended December 31, 2015 and 2014 was $0.14 and $0.32 per share, respectively. The total intrinsic value of options exercised during the years ended December 31, 2015 and 2014 was $0 and 14,650, respectively. The total fair value of shares vested during the years ended December 31, 2015 and 2014 was $265,247 and $143,382 respectively. As of December 31, 2015, future compensation cost related to nonvested stock options is $318,177 and will be recognized over an estimated weighted average period of 1.50 years.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration